Michael is a specialist pharmaceutical physician with over 20 years of clinical research experience in the industry. He has been involved in the clinical development of therapies in diverse therapeutic areas, including ophthalmology, cardiology, immunology and infectious diseases, and has supported successful registrations in the US, EU, China, Japan and Australia.

Michael obtained his medical degree from the University of Western Australia, his MBA from the Australian Graduate School of Management and is a Fellow of the Faculty of Pharmaceutical Medicine in the UK.